Clinical Trials Logo

Overweight and Obesity clinical trials

View clinical trials related to Overweight and Obesity.

Filter by:

NCT ID: NCT05098899 Active, not recruiting - Clinical trials for Overweight and Obesity

MyGeneMyDiet Trial for Weight Management

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The study aims to determine if genotype-based nutrition and lifestyle advice is effective for the management of overweight and obesity among Filipino adults compared to the usual standard of care.

NCT ID: NCT05083442 Active, not recruiting - Clinical trials for Overweight and Obesity

Low-level Laser and Lifestyle Modifications

LLLT
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaulate the effectiveness of Low Level Laser Therapy in combination with Lifestyle Modifications in helping people reduce the extra weight and size in the central body region

NCT ID: NCT05069298 Active, not recruiting - Clinical trials for Hypercholesterolemia

Effect of Silibinin(A) as a Potential Anti-obesity Agent

Start date: January 12, 2023
Phase: N/A
Study type: Interventional

Our preliminary reports have found in silico and in vitro that the milk thistle derivative Silibinin(A) is able to inhibit pancreatic lipase, in a similar way that the classical anti-obesity drug orlistat. Therefore, the investigators want to carry out the present trial in order to confirm that Silibinin(A) is able to in vivo inhibit pancreatic lipase, which will reduce the fat absorption and therefore will decrease the amount of energy from food intake. Considering that milk thistle has been extensively studied in humans as liver-protector, the investigators consider that the use of human subjects will be of great interest to accelerate the employment of this compound to improve the effectiveness of dietary treatment in overweight/obese subjects.

NCT ID: NCT04975763 Active, not recruiting - Clinical trials for Overweight and Obesity

Dietary Oils to Sustain Energy Study

DOSE
Start date: July 19, 2021
Phase: N/A
Study type: Interventional

The research study is an intervention and feasibility crossover design pilot study designed to assess if consuming 3 study foods made with either soybean oil or palm oil per day for 4 weeks can alter whole blood, plasma and erythrocyte fatty acids and body weight in overweight/obese adults. Additionally, the study will assess the adherence to consuming 3 study foods per day for 4 weeks and to assess if participant remain unaware of (or masked to) which study food group (soybean oil vs palm oil) they are consuming.

NCT ID: NCT04902417 Active, not recruiting - Inflammation Clinical Trials

Dairy and Inflammation Study

DRIVE
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether 6-weeks of increased dairy consumption can reduce inflammation and other markers of chronic disease while fasted or following a high-fat meal.

NCT ID: NCT04855552 Active, not recruiting - Clinical trials for Overweight and Obesity

Telehealth Weight Loss Program for Breast Cancer Survivors

TWL
Start date: July 19, 2021
Phase: N/A
Study type: Interventional

This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.

NCT ID: NCT04841265 Active, not recruiting - Clinical trials for Overweight and Obesity

The Effect of Vitamin D Supplementation in Overweight and Obese Pregnant Women

Start date: May 28, 2021
Phase: N/A
Study type: Interventional

To understand the role of vitamin D supplementation on pregnancy outcomes and metabolic status in overweight and obese pregnant women.

NCT ID: NCT04763772 Active, not recruiting - Type 2 Diabetes Clinical Trials

Clinical Effectiveness of Body Fat Distribution Imaging in Real-World Practice: The BODY-REAL Study

BODY-REAL
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The overall goal is to determine the real-world feasibility and utility of body fat imaging using rapid MRI to enhance risk perception, induce behavioral change, and improve clinical outcomes in overweight and obese individuals. Here, the investigators will perform a pragmatic clinical effectiveness pilot trial using a 2x2 factorial design to test the hypothesis that provision of a detailed individualized visual report of body fat distribution directly to patients will translate into changes in patient risk perception, behavior, and improved clinical outcomes.

NCT ID: NCT04759755 Active, not recruiting - Clinical trials for Overweight and Obesity

Circadian Timing, Information Processing and Energy Balance Study

TIME
Start date: May 29, 2019
Phase:
Study type: Observational

This study design will test biological and behavioral mechanisms in the cross-sectional analyses and determine the prospective effects of circadian alignment and sleep on changes in cardiometabolic risk factors.

NCT ID: NCT04631913 Active, not recruiting - Healthy Clinical Trials

Meta-analysis of Oats for Diabetes Prevention and Management

Start date: August 14, 2020
Phase:
Study type: Observational

Oats are a commonly consumed source of viscous soluble fibre, which has an established role in cardiovascular disease risk management including in cholesterol and glycemic control. Oat beta-glucan is recognized for its cholesterol-lowering effects with approved health claims in Canada, US and Europe. However, the efficacy of oat beta-glucan on glycemic control is not clear. We propose to conduct a systematic review and meta-analysis to explore the efficacy of whole grain oats and oat beta-glucan on markers of glycemic control in people with, without or at risk for diabetes.